Korro Bio, Inc.
KRRO
$13.28
-$0.01-0.08%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -43.11% | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -43.11% | -- | -- |
| Cost of Revenue | -33.39% | -37.64% | -39.35% | -13.94% | 22.26% |
| Gross Profit | 27.32% | 27.66% | 38.63% | 22.26% | -12.04% |
| SG&A Expenses | -14.93% | -1.93% | -22.97% | -11.18% | 1.27% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -26.68% | -25.88% | -32.14% | -12.73% | 13.70% |
| Operating Income | 22.56% | 18.32% | 31.06% | 17.41% | -7.64% |
| Income Before Tax | 27.01% | 16.49% | -134.20% | 14.03% | -18.23% |
| Income Tax Expenses | 10,700.00% | -- | 517.48% | -- | -96.67% |
| Earnings from Continuing Operations | 26.60% | 16.09% | -136.06% | 13.99% | -18.07% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 26.60% | 16.09% | -136.06% | 13.99% | -18.07% |
| EBIT | 22.56% | 18.32% | 31.06% | 17.41% | -7.64% |
| EBITDA | 20.20% | 15.71% | 30.08% | 19.48% | -5.72% |
| EPS Basic | 60.88% | 32.11% | -134.84% | 14.80% | -12.99% |
| Normalized Basic EPS | 59.14% | 32.43% | 29.77% | 14.84% | -7.72% |
| EPS Diluted | 60.88% | 32.11% | -134.84% | 14.80% | -12.99% |
| Normalized Diluted EPS | 59.14% | 32.43% | 29.77% | 14.84% | -7.72% |
| Average Basic Shares Outstanding | 87.62% | 23.60% | 0.51% | 0.95% | 4.50% |
| Average Diluted Shares Outstanding | 87.62% | 23.60% | 0.51% | 0.95% | 4.50% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |